- Exchange: NASDAQ GS
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Snapshot for Sequenom Inc (SQNM)
| Open: | 4.3700 | Day's Range: | 4.2300 - 4.3800 | Volume: | 2,035,725 | Bid: | 4.3200 |
|---|---|---|---|---|---|---|---|
| Previous Close: | 4.3400 | 52wk Range: | 3.5200 - 8.7100 | 1-Yr Rtn: | -44.97% | Ask: | 4.3300 |
Key Statistics for SQNM
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E (12/2012) | - |
| Earnings Per Share (USD) (ttm) | -0.8400 |
| Est. EPS (USD) (12/2012) | -0.7760 |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 494.82 |
| Shares Outstanding (M) | 114.54 |
| Enterprise Value (M USD) (ttm) | 392.32 |
| Enterprise Value/EBITDA (ttm) | - |
| Price/Book (mrq) | 3.8487 |
| Price/Sale (ttm) | 7.6823 |
| Dividend Indicated Gross Yield | 0.0000 |
| Next Earnings Announcement | 08/03/2012 |
More SQNM Key Statistics
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Financials for SQNM
- Operating
- Investing
- Financing (M/USD)
Company Profile & Key Executives for SQNM
Sequenom Inc. is a molecular diagnostic testing and genetics analysis company. The Company provides services, diagnostic testing, applications and genetic analysis products. Sequenom's products translate the results of genomic science into solutions for biomedical research, translational research, molecular medicine applications, and agricultural, livestock, and other areas of research.
| Harry F Hixson JrChairman/CEO | Paul V MaierChief Financial Officer |
| Charles R CantorChief Scientific Officer | Allan T BombardChief Medical Officer |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Links
Top Forex Trading Resources
Advertisement
Advertisement
Advertisements
Rate this Page